Correspondence

Advice on the classification and scheduling of Isotonitazene and related compounds

The government commissions the ACMD to advise on the appropriate classification and scheduling of Isotonitazene and related compounds.

• From: Advisory Council on the Misuse of Drugs
• Published: 21 January 2022

Documents

Letter from the Home Secretary to commission the ACMD for advice on the appropriate classification and scheduling of Isotonitazene and related compounds

HTML

Letter from the Home Secretary to commission the ACMD for advice on the appropriate classification and scheduling of Isotonitazene and related compounds

PDF, 127 KB, 2 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The government is writing to the Advisory Council on the Misuse of Drugs for advice on the appropriate classification and scheduling of Isotonitazene (and related compounds), CUMYL-PeGACLONE and Diphenidine under the Misuse of Drugs Act 1971, the Misuse of Drugs Regulations 2001 and, where appropriate, the Misuse of Drugs (Designation) Order 2015.

Published 21 January 2022